Lumipulse® G Pepsinogen I
Piecing together the risk factors for stomach cancer
Unique mono-test immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination of Pepsinogen I in human serum or plasma.
The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes.
Product number 292983
Product number 233450
-
Details
Product benefits:
-
Excellent precision: Typical total CV's: ≤2.2%
-
Wide dynamic range: 0.5 - 200 ng/mL
-
30-day calibration interval - no need to run a full calibration for just one sample
-
Minimal hands on time
-
Eliminates operator to operator issues associated with manual ELISA methods
-
Fast time to result - improved patient care
-
Unique mono test cartridge – excellent for low throughput assays
CLEIA - Chemiluminescent Enzyme Immunoassay
Test principle: Two-Step sandwich assay
See the LUMIPULSE G1200 working in this video:
-
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry
